Organisation paid for research Program year 2025 Source: CMS Open Payments

Midwest Vision Research Foundation

Neither a doctor nor a teaching hospital

Research payments

$628,226

182 payments

Through program year 2025, Midwest Vision Research Foundation is reported as receiving $628,226 in research payments, across 182 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$80,096	34
2024	Research	$200,540	55
2023	Research	$294,955	80
2022	Research	$38,646	6
2021	Research	$10,227	4
2020	Research	$1,000	2
2019	Research	$2,762	1

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $516,379 136 payments
AbbVie, Inc. $63,721 32 payments
F. Hoffmann-La Roche AG $19,200 1 payment
Regeneron Pharmaceuticals, Inc. $10,227 4 payments
Bausch & Lomb Americas Inc. $7,700 2 payments
Ocular Therapeutix, Inc. $4,250 1 payment
ANI Pharmaceuticals, Inc. $2,986 3 payments
Bausch Health US, LLC $2,762 1 payment
Allergan Inc. $1,000 2 payments

Studies the money was for Research payments · program years 2019–2025

Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $135,509 21 payments
Port Delivery System of Ranibizumab Extension Study $87,692 24 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $72,188 12 payments
A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $60,456 20 payments
Faricimab Dme Long Term Extension Rhone X $44,632 8 payments
Phase 2 of Ro7171009 in Ga $42,097 22 payments
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR $29,494 15 payments
Belvedere $21,322 8 payments
Patient Experience and Preference $19,200 1 payment
1698-302-007 Ph3 Extension Study (M21-489) $17,684 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.